Submission Details
| 510(k) Number | K070249 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 26, 2007 |
| Decision Date | April 26, 2007 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K070249 is an FDA 510(k) clearance for the ABX PENTRA 400, CALCIUM CP, CREATININE CP, PHOSPHORUS CP, AMYLASE CP, URINE CONTROL L/H, a Cresolphthalein Complexone, Calcium (Class II — Special Controls, product code CIC), submitted by Horiba Abx (Montpellier, FR). The FDA issued a Cleared decision on April 26, 2007, 90 days after receiving the submission on January 26, 2007. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1145.
| 510(k) Number | K070249 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 26, 2007 |
| Decision Date | April 26, 2007 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CIC — Cresolphthalein Complexone, Calcium |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1145 |